Trials / Sponsors / Lux Biosciences, Inc.

Lux Biosciences, Inc.

Industry · 7 registered clinical trials.

Status	Trial	Phase	Started
Completed	Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis Noninfectious Uveitis	Phase 3	2011-02-01
Completed	A Dose-Escalation Study to Assess the Safety and Tolerability of LX214 Ophthalmic Solution in Healthy Voluntee Keratoconjunctivitis Sicca	Phase 1	2009-02-01
Terminated	Study to Assess LX201 for Prevention of Corneal Allograft Rejection or Graft Failure in Subjects Who Have Expe Corneal Transplantation, Corneal Graft Rejection	Phase 3	2007-04-01
Terminated	Study to Assess the Efficacy and Safety of LX201 for Prevention of Corneal Allograft Rejection Episodes and Gr Corneal Diseases, Cornea Transplant	Phase 3	2007-04-01
Completed	A Study of LX211 in Clinically Quiescent Non-infectious Intermediate, Anterior and Intermediate, Posterior or Uveitis, Posterior, Uveitis, Intermediate, Panuveitis	Phase 3	2007-01-01
Completed	A Study of LX211 in Active Sight Threatening, Non-infectious Intermediate-, Anterior and Intermediate-, Poster Uveitis, Posterior, Uveitis, Intermediate, Panuveitis	Phase 3	2007-01-01
Completed	A Multi-center Study to Assess the Efficacy and Safety of LX211 in Active Non-infectious Anterior Uveitis Uveitis, Anterior, Panuveitis	Phase 3	2007-01-01